Figure1 (Valsartan Figure1)
This is a tabulated data presenting characteristics of patients in the study. The subgroups include Alpatients, age groups (<65y and ≥65y), gender (male and female), ethnicity (Caucasian and Non-Caucasian), region (US and non-US), and medication usage (Beta-blocker and No Beta-blocker). The table also shows the number of patients in each subgroup. A comparison section at the bottom indicates results favoring Valsartan versus Captopril.*